IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
Ryan Allway June 21st, 2022 News, Top News BETHESDA, Md., June 21, 2022–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. Researchers at the Jawaharlal Nehru Centre for... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )